Luo-Yi Wang Selected Research

1- (4- chlorophenylhydrazono)- 1- (4- chlorophenylamino)- 3,3- dimethyl- 2- butanone

1/2020

Sphingosine-1-phosphate receptor modulator FTY720 attenuates experimental myeloperoxidase-ANCA vasculitis in a T cell-dependent manner.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luo-Yi Wang Research Topics

Disease

2	Proteinuria 01/2020 - 11/2019
2	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2020 - 11/2019
1	Hemorrhage 01/2020
1	Hematuria 01/2020
1	Vasculitis (Vasculitides) 01/2020
1	Chronic Bronchitis 06/2010
1	Wounds and Injuries (Trauma) 06/2010

Drug/Important Bio-Agent (IBA)

2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2020 - 11/2019
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2020
1	1- (4- chlorophenylhydrazono)- 1- (4- chlorophenylamino)- 3,3- dimethyl- 2- butanoneIBA 01/2020
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2020
1	SEW2871IBA 01/2020
1	Peroxidase (Myeloperoxidase)IBA 01/2020
1	CreatinineIBA 11/2019
1	breyniaionoside EIBA 06/2010
1	SulfurIBA 06/2010
1	spiroketalIBA 06/2010
1	GlycosidesIBA 06/2010
1	breynin IIBA 06/2010

Therapy/Procedure

1	Chinese Traditional Medicine (Traditional Chinese Medicine) 06/2010